AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 83 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238,185 | -42.5% | 37,333 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $414,023 | -21.4% | 37,333 | +8.8% | 0.00% | -25.0% |
| Q1 2023 | $526,782 | -15.4% | 34,318 | +22.2% | 0.00% | -20.0% |
| Q4 2022 | $623,029 | +49.0% | 28,077 | +9.6% | 0.01% | +25.0% |
| Q3 2022 | $418,179 | +12.4% | 25,608 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $372,084 | +3.8% | 25,608 | +32.0% | 0.00% | +50.0% |
| Q1 2022 | $358,392 | +23.2% | 19,404 | +58.5% | 0.00% | 0.0% |
| Q4 2021 | $291,016 | -3.5% | 12,243 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $301,545 | -0.3% | 12,243 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $302,525 | +13.3% | 12,243 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $267,020 | +41.5% | 12,243 | +65.5% | 0.00% | +50.0% |
| Q4 2020 | $188,746 | -9.3% | 7,396 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $208,197 | – | 7,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 889,957 | $16,438,000 | 14.87% |
| Aaron Wealth Advisors LLC | 3,984,902 | $215,750,000 | 2.99% |
| Cormorant Asset Management, LP | 2,012,115 | $37,164,000 | 2.85% |
| GREAT POINT PARTNERS LLC | 500,000 | $9,235,000 | 2.23% |
| RTW INVESTMENTS, LP | 4,795,000 | $88,564,000 | 1.83% |
| EcoR1 Capital, LLC | 2,759,505 | $50,968,000 | 1.59% |
| 5AM Venture Management, LLC | 390,555 | $7,214,000 | 1.58% |
| Altium Capital Management LP | 243,000 | $4,488,000 | 1.50% |
| Octagon Capital Advisors LP | 321,641 | $5,941,000 | 1.28% |
| Boxer Capital, LLC | 1,121,327 | $20,711,000 | 1.06% |